MDPI and ACS Style
Yu, D.; Wagner, S.; Schütz, M.; Jeon, Y.; Seo, M.; Kim, J.; Brückner, N.; Kicuntod, J.; Tillmanns, J.; Wangen, C.;
et al. An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity. Pharmaceutics 2024, 16, 158.
https://doi.org/10.3390/pharmaceutics16020158
AMA Style
Yu D, Wagner S, Schütz M, Jeon Y, Seo M, Kim J, Brückner N, Kicuntod J, Tillmanns J, Wangen C,
et al. An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity. Pharmaceutics. 2024; 16(2):158.
https://doi.org/10.3390/pharmaceutics16020158
Chicago/Turabian Style
Yu, DongHoon, Sabrina Wagner, Martin Schütz, Yeejin Jeon, Mooyoung Seo, Jaeseung Kim, Nadine Brückner, Jintawee Kicuntod, Julia Tillmanns, Christina Wangen,
and et al. 2024. "An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity" Pharmaceutics 16, no. 2: 158.
https://doi.org/10.3390/pharmaceutics16020158